Literature DB >> 9619889

Depression and depressive symptoms in rheumatoid arthritis patients: an analysis of their occurrence and determinants.

A M Abdel-Nasser1, S Abd El-Azim, E Taal, S A El-Badawy, J J Rasker, H A Valkenburg.   

Abstract

The objectives were to determine the differences in depressive symptoms and depression between rheumatoid arthritis (RA) and osteoarthritis (OA) patients, and to analyse the contribution of sociodemographic and clinical variables to depression in RA patients. The responses of 60 Egyptian RA patients and 40 patients with OA of the knees to the Symptom Checklist-90-R Depression subscale were compared. The proportions of patients from both groups confirmed by a psychiatric interview to be clinically depressed according to the DSM-III-R criteria were also compared. The contributions of sociodemographic and disease variables to depressive symptoms and clinical depression in RA patients were explored by multiple linear and logistic regression, respectively. RA patients showed significantly higher depression scores than OA patients (P = 0.001). The difference was unaffected by controlling for the effects of age, sex, disease duration and the sociodemographic covariates. A depressive disorder was clinically confirmed in 23% of RA patients and 10% of OA patients. The erythrocyte sedimentation rate (ESR), being unmarried and an urban residence were significant predictors of depressive symptoms (P < 0.05), while being unmarried (P < 0.05, OR = 2.1) and HAQ disability (P < 0.01, OR = 3.8) were significant predictors of clinical depression in RA patients. RA patients have significantly more depressive symptoms and tend to be more clinically depressed than OA patients. The contribution of some sociodemographic and clinical variables to depression in RA patients was modest, albeit significant.

Entities:  

Mesh:

Year:  1998        PMID: 9619889     DOI: 10.1093/rheumatology/37.4.391

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  33 in total

1.  Association between SSRIs and upper gastrointestinal bleeding. Coprescription of antiulcer drugs with SSRIs is fairly common.

Authors:  D Williams; A Kelly; J Feely
Journal:  BMJ       Date:  2000-05-20

2.  Diagnosis and treatment of mood disorders in patients with rheumatic disease.

Authors:  M Alpay; E H Cassem
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

3.  The Relationship Between Anxiety, Depression, Suicidal Ideation and Quality of Life in Patients with Rheumatoid Arthritis.

Authors:  Aslı Beşirli; Jülide Öncü Alptekin; Derya Kaymak; Ömer Akil Özer
Journal:  Psychiatr Q       Date:  2020-03

4.  Temporal associations between the different domains of rheumatoid arthritis disease activity and the onset of patient-reported depressive symptoms.

Authors:  Alan M Rathbun; Leslie R Harrold; George W Reed
Journal:  Clin Rheumatol       Date:  2014-08-27       Impact factor: 2.980

5.  Depression and anxiety in rheumatoid arthritis: the role of perceived social support.

Authors:  Y Zyrianova; B D Kelly; C Gallagher; C McCarthy; M G Molloy; J Sheehan; T G Dinan
Journal:  Ir J Med Sci       Date:  2006 Apr-Jun       Impact factor: 1.568

6.  Psychological distress and personality traits in early rheumatoid arthritis: A preliminary survey.

Authors:  T N Hyphantis; M Bai; V Siafaka; A N Georgiadis; P V Voulgari; V Mavreas; A A Drosos
Journal:  Rheumatol Int       Date:  2005-12-09       Impact factor: 2.631

7.  Sensing the main health concerns in patients with established rheumatoid arthritis.

Authors:  Haider M Al Attia; Maysa Al Abbasi
Journal:  Clin Rheumatol       Date:  2011-09-27       Impact factor: 2.980

8.  Depression in patients with rheumatoid arthritis: description, causes and mechanisms.

Authors:  Mary Margaretten; Laura Julian; Patricia Katz; Edward Yelin
Journal:  Int J Clin Rheumtol       Date:  2011

Review 9.  Healthcare burden of depression in adults with arthritis.

Authors:  Usha Sambamoorthi; Drishti Shah; Xiaohui Zhao
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2017-01-20       Impact factor: 2.217

Review 10.  Management of co-morbidities and general medical conditions in patients with rheumatoid arthritis.

Authors:  Molly D Magnano; Mark C Genovese
Journal:  Curr Rheumatol Rep       Date:  2005-10       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.